Latigo Biotherapeutics Files for IPO, Fueling Non-Opioid Pain Drug Race Amidst Robust Biotech Market Activity
Westlake, CA – July 20, 2026 – Latigo Biotherapeutics, a pioneering biotechnology firm headquartered in...
Knowledge and News for the Global Fight Against Cancer.
Westlake, CA – July 20, 2026 – Latigo Biotherapeutics, a pioneering biotechnology firm headquartered in...
The biotechnology sector’s resurgence on public markets gained further traction this week with Attovia Therapeutics...
New data emerging from a clinical trial conducted in China have provided what Wall Street...
The pharmaceutical industry stands at a pivotal juncture, with artificial intelligence (AI) heralded as a...
The 2026 American Association of Cancer Research (AACR) Annual Meeting, held in San Diego from...
London-based pharmaceutical giant GSK has announced the discontinuation of its camlipixant development program, a P2X3...
At the prestigious 2026 AACR Annual Meeting, held as a pivotal gathering for the global...
The biopharmaceutical industry finds itself navigating a complex legal and scientific terrain this week, marked...
The sun went down hours ago, casting the world outside into shadow, yet inside a...
In a pivotal move to reverse its flagging fortunes, Jasper Therapeutics, a biotechnology company that...